BREAKING
Dogwood Therapeutics (DWTX) Q4 Loss Narrows to $0.26, Beats Estimates 3 hours ago General Mills (GIS) Q3 EPS Misses by 12% at $0.64 as Revenue Falls 8% YoY to $4.44B 4 hours ago Star Equity Holdings Slips to a Loss in Q4 FY25; Revenue Surges 69% to $56.8M 4 hours ago Ovid Therapeutics (OVID) Swings to $0.06 EPS in Q4 FY25 4 hours ago Giftify, Inc. (GIFT) Narrows Loss Q4 EPS Estimates by 11.0% 4 hours ago Weibo Corporation (WB) Misses Q4 EPS Estimates 4 hours ago ADMA CEO Adam Grossman Sells 15,000 Shares at $15.16 Amid 125K Share Insider Selloff 4 hours ago AESI CEO Forfeits Shares at $13.60 as Six-Month Insider Selling Trend Reaches 582,124 Shares 5 hours ago Ulta Beauty CEO Kecia Steelman Surrenders 1,491 Shares at $535.72 in Tax Withholding Transaction 5 hours ago BLDR CEO Peter Jackson and 7 Executives Surrender $2.77M in Shares for Tax Withholdings 5 hours ago Dogwood Therapeutics (DWTX) Q4 Loss Narrows to $0.26, Beats Estimates 3 hours ago General Mills (GIS) Q3 EPS Misses by 12% at $0.64 as Revenue Falls 8% YoY to $4.44B 4 hours ago Star Equity Holdings Slips to a Loss in Q4 FY25; Revenue Surges 69% to $56.8M 4 hours ago Ovid Therapeutics (OVID) Swings to $0.06 EPS in Q4 FY25 4 hours ago Giftify, Inc. (GIFT) Narrows Loss Q4 EPS Estimates by 11.0% 4 hours ago Weibo Corporation (WB) Misses Q4 EPS Estimates 4 hours ago ADMA CEO Adam Grossman Sells 15,000 Shares at $15.16 Amid 125K Share Insider Selloff 4 hours ago AESI CEO Forfeits Shares at $13.60 as Six-Month Insider Selling Trend Reaches 582,124 Shares 5 hours ago Ulta Beauty CEO Kecia Steelman Surrenders 1,491 Shares at $535.72 in Tax Withholding Transaction 5 hours ago BLDR CEO Peter Jackson and 7 Executives Surrender $2.77M in Shares for Tax Withholdings 5 hours ago
ADVERTISEMENT
Market News

CorVel reports higher December-quarter revenue and earnings

CorVel Corporation (NASDAQ: CRVL) provides technology-enabled services for claims management, medical cost containment, and analytics-driven workflows. The company operates across its Property & Casualty and CERIS platforms. Financial Performance For the quarter ended December 31, 2025, CorVel reported revenue of $235.6 million, compared with $228.0 million in the same quarter of the prior year. Gross […]

February 3, 2026 2 min read

CorVel Corporation (NASDAQ: CRVL) provides technology-enabled services for claims management, medical cost containment, and analytics-driven workflows. The company operates across its Property & Casualty and CERIS platforms. Financial Performance For the quarter ended December 31, 2025, CorVel reported revenue of $235.6 million, compared with $228.0 million in the same quarter of the prior year. Gross […]

CorVel Corporation (NASDAQ: CRVL) provides technology-enabled services for claims management, medical cost containment, and analytics-driven workflows. The company operates across its Property & Casualty and CERIS platforms.

Financial Performance

For the quarter ended December 31, 2025, CorVel reported revenue of $235.6 million, compared with $228.0 million in the same quarter of the prior year. Gross profit increased to $54.9 million from $52.9 million a year earlier. Net income for the quarter was $24.2 million, compared with $23.8 million in the prior-year period. Diluted earnings per share increased to $0.47 from $0.46.

For the nine months ended December 31, 2025, revenue totaled $710.0 million, up from $664.1 million in the corresponding period a year earlier. Net income for the nine-month period was $79.3 million, compared with $68.7 million in the prior-year period.

Operating Metrics

The charts below present operating metrics. Metrics shown include quarterly revenue, gross profit with earnings per share trend, and nine-month revenue.

Chart 1 — Quarterly Revenue Comparison

Chart 2 — Gross Profit and EPS Trend

Chart 3 — Nine-Month Revenue Trend

Key Developments

During the quarter, CorVel exited the period with $230.0 million in cash and cash equivalents and no borrowings. The company repurchased $13.4 million of common stock during the quarter. Management reported continued progress in advancing automation and artificial intelligence initiatives.

Risks and Constraints

The company operates in a regulated environment and is exposed to risks related to regulatory change, medical cost trends, competitive pressures, and execution of technology initiatives.

Outlook / Guidance

The company did not provide long-term quantitative guidance. What to watch for includes revenue trends, operating margin movement, progress on technology initiatives, and capital allocation activity.

Performance Summary

CorVel reported year-over-year increases in revenue, gross profit, and earnings per share for the December quarter. Nine-month revenue also increased compared with the prior-year period.

ADVERTISEMENT